|
Market Closed -
NYSE
01:30:03 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 18.19 USD | -2.26% |
|
-1.89% | -23.67% |
| 22/10 | Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell | MT |
| 21/10 | Wedbush Adjusts Price Target on Arcus Biosciences to $49 From $43, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.26% | -1.89% | -29.58% | -35.61% | -23.67% | -9.91% | +21.67% | -45.60% | - | 261.5Cr | |
| -0.62% | -1.87% | -15.14% | +13.17% | +56.67% | +46.31% | +56.99% | +2.90% | - | 6.38TCr | |
| +0.35% | +3.20% | -4.68% | +8.12% | +12.61% | +14.92% | +84.55% | +211.78% | +5,536.87% | 5.64TCr | |
| +0.53% | +1.96% | +12.00% | +12.98% | +19.78% | +15.37% | +106.81% | -14.18% | +241.75% | 5.46TCr | |
| -2.81% | -4.31% | -0.57% | +12.42% | +18.60% | +23.50% | +50.90% | +2.26% | +272.48% | 4.41TCr | |
| -0.33% | -1.93% | +1.20% | +14.98% | +21.90% | +20.15% | +98.45% | +3.53% | +1,006.45% | 4.21TCr | |
| +0.55% | +2.31% | -6.80% | -0.45% | +140.19% | +224.97% | +942.56% | +550.05% | - | 4.1TCr | |
| +3.27% | +47.96% | +66.97% | +112.15% | +92.99% | +112.67% | +96.48% | +35.64% | +246.19% | 3.49TCr | |
| +1.22% | -1.44% | +7.82% | +0.84% | +11.15% | +14.89% | +47.15% | +16.23% | +160.92% | 3.28TCr | |
| +0.89% | +20.55% | -1.37% | +10.93% | -35.31% | -42.03% | +373.03% | +273.40% | +731.46% | 2.47TCr | |
| -1.29% | -2.88% | -20.64% | +17.67% | +41.48% | +21.60% | -11.92% | -62.43% | - | 2.33TCr | |
| -1.08% | +0.06% | -10.31% | -5.04% | -7.38% | -15.76% | -5.45% | -68.37% | - | 2.21TCr | |
| -3.77% | -2.57% | +4.46% | +12.75% | +16.09% | +12.34% | +169.65% | +187.80% | +2,156.87% | 1.82TCr | |
| -4.44% | +4.07% | +21.83% | +53.19% | +80.17% | +100.66% | +118.46% | -19.90% | +372.91% | 1.72TCr | |
| +0.73% | +3.57% | +16.96% | +27.87% | +40.58% | +44.70% | +87.72% | -13.95% | +113.82% | 1.7TCr | |
| -0.68% | +3.25% | +10.29% | +0.08% | - | - | - | - | - | 1.65TCr | |
| +4.82% | +7.53% | +18.80% | +23.98% | +58.32% | +78.20% | +242.84% | +222.59% | +537.78% | 1.72TCr | |
| -1.91% | +14.08% | +24.34% | +27.69% | +15.99% | +27.84% | -11.24% | -26.30% | +163.15% | 1.58TCr | |
| -4.03% | +2.59% | -2.06% | +16.10% | +180.86% | +168.30% | +345.93% | +1,407.09% | +787.81% | 1.51TCr | |
| -7.22% | +6.81% | -11.82% | +63.06% | +22.30% | -16.29% | - | - | - | 1.3TCr | |
| Average | -0.90% | +5.12% | +4.09% | +19.34% | +40.17% | +44.34% | +156.36% | +147.92% | +948.34% | 2.86TCr | |
| Weighted average by Cap. | -0.41% | +4.71% | +4.17% | +19.43% | +41.40% | +46.92% | +163.75% | +123.63% | +1,238.16% |
- Stock Market
- Stocks
- RCUS Stock
- Sector Arcus Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
